Adial Pharmaceuticals (ADIL)
(Delayed Data from NSDQ)
$0.46 USD
+0.02 (4.36%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $0.39 -0.07 (-14.30%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth A Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Adial Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ADIL 0.46 +0.02(4.36%)
Will ADIL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ADIL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ADIL
Adial Pharmaceuticals (ADIL) Upgraded to Strong Buy: Here's Why
Adial Pharmaceuticals (ADIL) Upgraded to Buy: Here's What You Should Know
ADIL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ADIL
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's After-Market Session
Adial Pharmaceuticals (ADIL) Regains Nasdaq Compliance | ADIL Stock News
Adial Pharmaceuticals regains compliance with Nasdaq stockholders’ equity listing requirement